Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report-Reference-Cited by-同舟云学术

Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report

Published:2023-05-06 Issue:8 Volume:102 Page:2271-2273
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Yu Ning,Liu Xiaojun,Liu Chao,Tian Wenbin,Li Weihao,Liu Ya

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05244-z.pdf

Reference9 articles.

1. Ang AL, Kuperan P, Ng CH, Ng HJ (2009) Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost 101(5):852–859. https://doi.org/10.1160/th08-11-0767

2. Park GH, Kim S, Kim MS, Yu YM, Kim GH, Lee JS et al (2019) The association between cephalosporin and hypoprothrombinemia: a systematic review and meta-analysis. Int J Environ Res Public Health 16(20):3937. https://doi.org/10.3390/ijerph16203937

3. Cui QY, Shen HS, Wu TQ, Chen HF, Yu ZQ, Wang ZY (2015) Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature. Drug Des Devel Ther 9:2395–2398. https://doi.org/10.2147/dddt.S68682

4. Sridharan M, Fylling KA, Ashrani AA, Chen D, Marshall AL, Hook CC et al (2018) Clinical and laboratory diagnosis of autoimmune factor V inhibitors: a single institutional experience. Thromb Res 171:14–21. https://doi.org/10.1016/j.thromres.2018.09.044

5. Olson NJ, Ornstein DL (2017) Factor V inhibitors: a diagnostic and therapeutic challenge. Arch Pathol Lab Med 141(12):1728–1731. https://doi.org/10.5858/arpa.2016-0445-RS